Publications by authors named "Michael Entzeroth"

Claim this Profile
D
Differential scanning fluorimetry as secondary screening platform for small molecule inhibitors of Bcl-XL.
Kah Fei Wan, Sifang Wang, Christopher J Brown, Victor C Yu, Michael Entzeroth

Cell Cycle· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
Haishan Wang, Niefang Yu, Hongyan Song, Dizhong Chen, Yong Zou, Michael Entzeroth

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of high-throughput screening.
Michael Entzeroth, Horst Flotow, Peter Condron

Curr Protoc Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics as knowledge enterprise: Implementing an electronic research habitat at the Biopolis Experimental Therapeutics Center.
Wayne Mitchell, Colin Breen, Michael Entzeroth

Biotechnol J· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Function of the SIRT1 protein deacetylase in cancer.
Walter Stünkel, Bee Keow Peh, Yong Cheng Tan, Vasantha M Nayagam, Xukun Wang, Michael Entzeroth

Biotechnol J· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Singapore--creation of a scientific hub in Southeast Asia.
Michael Entzeroth

Biotechnol J· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents.
Vasantha M Nayagam, Xukun Wang, Yong Cheng Tan, Anders Poulsen, Kee Chuan Goh, Michael Entzeroth

J Biomol Screen· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
Klaus Rudolf, Wolfgang Eberlein, Wolfhard Engel, Helmut Pieper, Michael Entzeroth

J Med Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging trends in high-throughput screening.
Michael Entzeroth

Curr Opin Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis